Flosonics Medical

Flosonics Medical is a medical technology company dedicated to developing non-invasive hemodynamic monitoring devices to enhance the care of critically ill patients. The company focuses on providing real-time, actionable hemodynamic information at the point of care, utilizing expertise in ultrasound technology and critical care. Their flagship product, the FloPatch, is the first wireless, wearable Doppler ultrasound patch that offers continuous, real-time hemodynamic assessments. This disposable sensor is designed for use in various critical care environments, including ambulances, emergency departments, and intensive care units. The FloPatch supports effective fluid resuscitation and management, complying with established clinical guidelines and requiring minimal training for healthcare providers. Flosonics Medical's technology addresses important clinical needs by providing a rapid, non-invasive method for fluid therapy management. The company holds multiple patents for its innovations, emphasizing its commitment to advancing medical device technology. Flosonics Medical has received recognition for its contributions to digital health, including the 2023 Digital Health Hub Foundation Award in the Rising Star category for Clinical Diagnostic Device.

• Employees 68
• Founded 2015
• Annual Revenue $55000000
• Total Funding $46183318